Add-on sirolimus in refractory iMCD-TAFRO: a TAFRO-enriched 8-patient case series with paired single-cell profiling.
- DOI
- 10.3389/fimmu.2026.1963440
- Published
- 2026
- Container
- Frontiers in immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2026.1963440,
title = {Add-on sirolimus in refractory iMCD-TAFRO: a TAFRO-enriched 8-patient case series with paired single-cell profiling.},
author = {Sumiyoshi R and Koga T and Michitsuji T and Umeda M and Takatani A and Nishimura Y and Fajgenbaum DC and van Rhee F and Kawakami A},
year = {2026},
journal = {Frontiers in immunology},
doi = {10.3389/fimmu.2026.1963440},
url = {https://doi.org/10.3389/fimmu.2026.1963440}
}RIS
TY - JOUR TI - Add-on sirolimus in refractory iMCD-TAFRO: a TAFRO-enriched 8-patient case series with paired single-cell profiling. AU - Sumiyoshi R AU - Koga T AU - Michitsuji T AU - Umeda M AU - Takatani A AU - Nishimura Y AU - Fajgenbaum DC AU - van Rhee F AU - Kawakami A PY - 2026 JO - Frontiers in immunology DO - 10.3389/fimmu.2026.1963440 UR - https://doi.org/10.3389/fimmu.2026.1963440 ER -
APA
R, S., T, K., T, M., M, U., A, T., Y, N., DC, F., F, V. R., & A, K. (2026). Add-on sirolimus in refractory iMCD-TAFRO: a TAFRO-enriched 8-patient case series with paired single-cell profiling.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1963440
Source records
- pubmed · retrieved 2026-11-10T14:01:15.719Z